Cognition Therapeutics annual depreciation and amortization
2020
2021
2022
2023
2024
2025
Cognition Therapeutics Depreciation & Amortization Growth & History (CGTX)
Cognition Therapeutics's depreciation and amortization was $36,000 for fiscal 2025.
View full Cognition Therapeutics company overviewCognition Therapeutics annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $36,000 | −$71,000 | −66.36% |
| 2024 | 2024-12-31 | $107,000 | $11,000 | +11.46% |
| 2023 | 2023-12-31 | $96,000 | $13,000 | +15.66% |
| 2022 | 2022-12-31 | $83,000 | −$10,000 | −10.75% |
| 2021 | 2021-12-31 | $93,000 | −$5,000 | −5.10% |
| 2020 | 2020-12-31 | $98,000 | — | — |
Cognition Therapeutics quarterly depreciation and amortization
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $55,000 | −$6,000 | −9.84% |
| Q1 2026 | 2026-03-31 | $68,000 | — | — |
| Q4 2025 | 2025-12-31 | $61,000 | — | — |
| Q3 2025 | 2025-09-30 | $15,000 | −$12,000 | −44.44% |
| Q2 2025 | 2025-06-30 | $61,000 | $35,000 | +134.62% |
| Q3 2024 | 2024-09-30 | $27,000 | $2,000 | +8.00% |
| Q2 2024 | 2024-06-30 | $26,000 | $3,000 | +13.04% |
| Q1 2024 | 2024-03-31 | $27,000 | $6,000 | +28.57% |
| Q3 2023 | 2023-09-30 | $25,000 | $3,000 | +13.64% |
| Q2 2023 | 2023-06-30 | $23,000 | $3,000 | +15.00% |
| Q1 2023 | 2023-03-31 | $21,000 | $3,000 | +16.67% |
| Q3 2022 | 2022-09-30 | $22,000 | −$1,000 | −4.35% |
| Q2 2022 | 2022-06-30 | $20,000 | −$4,000 | −16.67% |
| Q1 2022 | 2022-03-31 | $18,000 | −$5,000 | −21.74% |
| Q3 2021 | 2021-09-30 | $23,000 | — | — |
| Q2 2021 | 2021-06-30 | $24,000 | — | — |
| Q1 2021 | 2021-03-31 | $23,000 | — | — |
Cognition Therapeutics depreciation and amortization trends
Over the last five fiscal years, Cognition Therapeutics's depreciation and amortization decreased from $98,000 to $36,000, a change of −$62,000. The latest reported quarter, Q2 2026, shows $55,000.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cognition Therapeutics source filings ↗